Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

2017; National Comprehensive Cancer; Volume: 15; Issue: 7 Linguagem: Inglês

10.6004/jnccn.2017.0116

ISSN

1540-1413

Autores

Margaret O’Donnell, Martin S. Tallman, Camille N. Abboud, Jessica K. Altman, Frederick R. Appelbaum, Daniel A. Arber, Vijaya Raj Bhatt, Dale L. Bixby, William Blum, Steven Coutré, Marcos de Lima, Amir T. Fathi, Melanie Fiorella, James M. Foran, Steven D. Gore, Aric C. Hall, Patricia Kropf, Jeffrey E. Lancet, Lori J. Maness, Guido Marcucci, Michael G. Martin, Joseph O. Moore, Rebecca L. Olin, Deniz Peker, Daniel A. Pollyea, Keith W. Pratz, Farhad Ravandi, Paul J. Shami, Richard M. Stone, Stephen A. Strickland, Eunice S. Wang, Matthew J. Wieduwilt, Kristina M. Gregory, Ndiya Ogba,

Tópico(s)

Hematological disorders and diagnostics

Resumo

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. This portion of the NCCN Guidelines for AML focuses on management and provides recommendations on the workup, diagnostic evaluation, and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.

Referência(s)